Artemisinin - CAS 63968-64-9
Catalog number: 63968-64-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C15H22O5
Molecular Weight:
282.33
COA:
Inquire
Targets:
HCV
Description:
Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
Grigg MJ1, William T2, Menon J3, Barber BE1, Wilkes CS1, Rajahram GS4, Edstein MD5, Auburn S6, Price RN7, Yeo TW8, Anstey NM9. Clin Infect Dis. 2016 Apr 22. pii: ciw121. [Epub ahead of print]
BACKGROUND:  Chloroquine (CQ)-resistant Plasmodium vivax is increasingly reported throughout southeast Asia. The efficacy of CQ and alternative artemisinin combination therapies (ACTs) for vivax malaria in Malaysia is unknown.
2.Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Tong Y1,2, Liu Y1,2, Zheng H2, Zheng L1,2, Liu W1,2, Wu J2, Ou R2, Zhang G2, Li F2, Hu M2,3, Liu Z1,2, Lu L2. Oncotarget. 2016 Apr 22. doi: 10.18632/oncotarget.8920. [Epub ahead of print]
Non-small-cell lung cancer (NSCLC) is the most prevalent malignancy worldwide given its high incidence, considerable mortality, and poor prognosis. The anti-malaria compounds artemisinin (ART), dihydroartemisinin (DHA), and artesunate (ARTS) reportedly have anti-cancer potential, although the underlying mechanisms remain unclear. In this work, we used flow cytometry to show that ART, DHA, and ARTS could inhibit the proliferation of A549 and H1299 cells by arresting cell cycle in G1 phase. Meanwhile, tumor malignancy including migration, invasion, cancer stem cells, and epithelial-mesenchymal transition were also significantly suppressed by these compounds. Furthermore, ART, DHA, and ARTS remarkably decreased tumor growth in vivo. By using IWP-2, the inhibitor of Wnt/β-catenin pathway, and Wnt5a siRNA, we found that ART, DHA, and ARTS could render tumor inhibition partially dependent on Wnt/β-catenin inactivation. These compounds could strikingly decrease the protein level of Wnt5-a/b and simultaneously increase those of NKD2 and Axin2, ultimately resulting in β-catenin downregulation.
3.Artesunate inhibits adipogeneis in 3T3-L1 preadipocytes by reducing the expression and/or phosphorylation levels of C/EBP-α, PPAR-γ, FAS, perilipin A, and STAT-3.
Jang BC1. Biochem Biophys Res Commun. 2016 Apr 21. pii: S0006-291X(16)30614-3. doi: 10.1016/j.bbrc.2016.04.109. [Epub ahead of print]
Differentiation of preadipocyte, also called adipogenesis, leads to the phenotype of mature adipocyte. However, excessive adipogenesis is closely linked to the development of obesity. Artesunate, one of artemisinin-type sesquiterpene lactones from Artemisia annua L., is known for anti-malarial and anti-cancerous activities. In this study, we investigated the effect of artesunate on adipogenesis in 3T3-L1 preadipocytes. Artesunate strongly inhibited lipid accumulation and triglyceride (TG) synthesis during the differentiation of 3T3-L1 preadipocytes into adipocytes at 5 μM concentration. Artesunate at 5 μM also reduced not only the expressions of CCAAT/enhancer-binding protein-α (C/EBP-α), peroxisome proliferator-activated receptor-γ (PPAR-γ), fatty acid synthase (FAS), and perilipin A but also the phosphorylation levels of signal transducer and activator of transcription-3 (STAT-3) during adipocyte differentiation. Moreover, artesunate at 5 μM reduced leptin, but not adiponectin, mRNA expression during adipocyte differentiation.
4.Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Tong Y1,2, Liu Y1,2, Zheng H2, Zheng L1,2, Liu W1,2, Wu J2, Ou R2, Zhang G2, Li F2, Hu M2,3, Liu Z1,2, Lu L2. Oncotarget. 2016 Apr 22. doi: 10.18632/oncotarget.8920. [Epub ahead of print]
Non-small-cell lung cancer (NSCLC) is the most prevalent malignancy worldwide given its high incidence, considerable mortality, and poor prognosis. The anti-malaria compounds artemisinin (ART), dihydroartemisinin (DHA), and artesunate (ARTS) reportedly have anti-cancer potential, although the underlying mechanisms remain unclear. In this work, we used flow cytometry to show that ART, DHA, and ARTS could inhibit the proliferation of A549 and H1299 cells by arresting cell cycle in G1 phase. Meanwhile, tumor malignancy including migration, invasion, cancer stem cells, and epithelial-mesenchymal transition were also significantly suppressed by these compounds. Furthermore, ART, DHA, and ARTS remarkably decreased tumor growth in vivo. By using IWP-2, the inhibitor of Wnt/β-catenin pathway, and Wnt5a siRNA, we found that ART, DHA, and ARTS could render tumor inhibition partially dependent on Wnt/β-catenin inactivation. These compounds could strikingly decrease the protein level of Wnt5-a/b and simultaneously increase those of NKD2 and Axin2, ultimately resulting in β-catenin downregulation.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HCV Products


CAS 442666-98-0 Anguizole

Anguizole
(CAS: 442666-98-0)

Anguizole is a small molecule inhibitor of HCV replication and alters NS4B's subcellular distribution.

Elbasvir
(CAS: 1370468-36-2)

Elbasvir has been found to restrain viral phosphoprotein so that could be used against hepatitis C virus and is currently under Phase II trail.

CAS 1502655-48-2 Ledipasvir diacetone

Ledipasvir diacetone
(CAS: 1502655-48-2)

Against JFH1/3a-NS5A, DCV was more potent (EC(50) = 0.52 nM) than GS-5885 (EC(50) = 141 nM). DCV sensitivity was increased against JFH1/3a-NS5A-M28V (EC50 = 0.0...

CAS 1350514-68-9 MK-5172

MK-5172
(CAS: 1350514-68-9)

In biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical stu...

CAS 478182-28-4 R-1479

R-1479
(CAS: 478182-28-4)

R1479 is a potent and highly specific inhibitor of HCV replication in cell culture, and that its triphosphate is a potent and highly selective inhibitor of NS5B...

CAS 863329-66-2 PSI-6206

PSI-6206
(CAS: 863329-66-2)

PSI-6206 (RO2433) is a selective HCV RNA polymerase inhibitor. It is the unphosphorylated parent compound of triphosphate analog PSI-7409, which is a potent inh...

ACH-806
(CAS: 870142-71-5)

ACH-806 is a Hepatitis C virus NS3 protein inhibitor. It can inhibit viral RNA replication in HCV replicon cells and is active in genotype 1 HCV-infected patien...

CAS 1502654-87-6 Ledipasvir D-tartrate

Ledipasvir D-tartrate
(CAS: 1502654-87-6)

Against JFH1/3a-NS5A, DCV was more potent (EC(50) = 0.52 nM) than GS-5885 (EC(50) = 141 nM). DCV sensitivity was increased against JFH1/3a-NS5A-M28V (EC50 = 0.0...

CAS 300832-84-2 Ciluprevir

Ciluprevir
(CAS: 300832-84-2)

Ciluprevir is used experimentally in the treatment of hepatitis C. It is manufactured by Boehringer Ingelheim Pharma GmbH & Co. kg and developed under the resea...

Radalbuvir
(CAS: 1314795-11-3)

Radalbuvir is a Hepatitis C virus NS 5 protein inhibitor for the treatment of hepatitis C virus (HCV) infection developed by Gilead Sciences. In 2014, Gilead co...

CAS 850876-88-9 Danoprevir

Danoprevir
(CAS: 850876-88-9)

Danoprevir(ITMN-191;R7227; RO5190591;RG7227) is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with IC50 of 0.2-3.5 nM, inhibition...

CAS 1350462-55-3 MK-5172 hydrate

MK-5172 hydrate
(CAS: 1350462-55-3)

In biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical stu...

CAS 1000787-75-6 Tegobuvir

Tegobuvir
(CAS: 1000787-75-6)

Tegobuvir is a non-nucleoside nonstructural protein (NS)5B polymerase inhibitor.

CAS 254435-95-5 Alisporivir

Alisporivir
(CAS: 254435-95-5)

Alisporivir, also known as DEB-025, a non-immunosuppressive cyclosporine A derivative, is acyclophil ininhibitor molecule with potent anti-hepatitis C virus (HC...

CAS 958002-33-0 Beclabuvir

Beclabuvir
(CAS: 958002-33-0)

Beclabuvir is a potent, non-nucleotide inhibitor of HCV NS5B which is currently in Phase III clinical trials for the treatment of chronic HCV infection. Beclabu...

CAS 1026785-59-0 VX-222 (VCH-222, Lomibuvir)

VX-222 (VCH-222, Lomibuvir)
(CAS: 1026785-59-0)

VX-222 (VCH-222) is a novel, potent and selective inhibitor of HCV polymerase with IC50 of 0.94-1.2 μM, 15.3-fold less effective for mutant M423T, and 108-fold ...

CAS 81485-25-8 Peretinoin

Peretinoin
(CAS: 81485-25-8)

Peretinoin, also known as NIK-333, orally available, acyclic retinoid with potential antineoplastic and chemopreventive activities. Peretinoin binds to and acti...

CAS 1425038-27-2 MK-5172 sodium salt

MK-5172 sodium salt
(CAS: 1425038-27-2)

In biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical stu...

CAS 630420-16-5 Asunaprevir

Asunaprevir
(CAS: 630420-16-5)

Asunaprevir is a potent hepatitis C virus (HCV) non-structural protein protease inhibitor currently in Phase III clinical trials for the treatment of HCV infect...

CAS 876708-03-1 RO-9187

RO-9187
(CAS: 876708-03-1)

RO-9187 is a potent inhibitor of HCV virus replication in the replicon system. It is excellent substrates for deoxycytidine kinase and were phosphorylated with ...

Chemical Structure

CAS 63968-64-9 Artemisinin

Quick Inquiry

Verification code

Featured Items